Furthermore in this study, LRRTM3 SNP multilocus genotypes (MLGs) were shown to have statistical interactions with PLAU, previously implicated in AD risk and Aβ levels [16], as well as CDC2 and ACE in conferring AD risk. Here, LRRTM3 is linked to Alzheimer disease.